SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-178715
Filing Date
2018-05-30
Accepted
2018-05-30 17:17:04
Documents
6
Period of Report
2018-05-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d595223d8k.htm 8-K 31831
2 EX-10.1 d595223dex101.htm EX-10.1 18162
3 EX-10.2 d595223dex102.htm EX-10.2 39914
4 EX-99.1 d595223dex991.htm EX-99.1 14526
5 GRAPHIC g595223g0530080508996.jpg GRAPHIC 2612
6 GRAPHIC g595223g0530083828122.jpg GRAPHIC 3263
  Complete submission text file 0001193125-18-178715.txt   114187
Mailing Address 175 PORTLAND STREET 4TH FLOOR BOSTON MA 02114
Business Address 175 PORTLAND STREET 4TH FLOOR BOSTON MA 02114 617-622-4003
ZAFGEN, INC. (Filer) CIK: 0001374690 (see all company filings)

IRS No.: 203857670 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36510 | Film No.: 18869116
SIC: 2834 Pharmaceutical Preparations